Tofacitinib Helps in Ulcerative Colitis (CME/CE)
(MedPage Today) — The oral JAK inhibitor tofacitinib, currently under FDA review for treating rheumatoid arthritis, also showed promise for ulcerative colitis in a randomized trial.
(MedPage Today) — The oral JAK inhibitor tofacitinib, currently under FDA review for treating rheumatoid arthritis, also showed promise for ulcerative colitis in a randomized trial.
Comments are closed.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information: verify here.